Fowler C J, Wiberg A
Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):77-84. doi: 10.1007/BF00505807.
The monoamine oxidase B (MAO-B) selective inhibitor J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium chloride) appears to interact with MAO-B in a manner consistent with a "suicide" reaction. Because of this property, J-508 could be used, under the appropriate conditions, to "titrate" the concentration of MAO-B active centres in the human platelet, although some non-specific binding of this compound to sites other than the active centre of this enzyme form was found, thus limiting the accuracy of the titration method. The molecular characteristics of human platelet MAO-B (Km, Vmax, approximate enzyme concentrations and molecular turnover members) towards three of its monoamine substrates have been estimated. The natural variation of platelet MAO-B activity from individual to individual is due to a variation in the Vmax without a variation in the Km towards benzylamine is substrate, and is based, at least in part, upon a variation in the concentration of this enzyme form.
单胺氧化酶B(MAO - B)选择性抑制剂J - 508(N - 甲基 - N - 炔丙基 -(1 - 茚满基)氯化铵)似乎以与“自杀”反应一致的方式与MAO - B相互作用。由于这一特性,在适当条件下,J - 508可用于“滴定”人血小板中MAO - B活性中心的浓度,尽管发现该化合物与这种酶形式活性中心以外的位点存在一些非特异性结合,从而限制了滴定方法的准确性。已估计人血小板MAO - B对其三种单胺底物的分子特性(米氏常数(Km)、最大反应速度(Vmax)、近似酶浓度和分子周转数)。个体间血小板MAO - B活性的自然差异是由于Vmax的变化,而对底物苄胺的Km没有变化,并且至少部分基于这种酶形式浓度的变化。